Discontinuation of benzodiazepines after long‐term use increases mortality risk

A comparative effectiveness study using a U.S. commercial insurance database has found small increases in risk of mortality and other adverse outcomes when benzodiazepine treatment is discontinued in long‐term users. Mortality risk was higher in subgroups of discontinuers both with and without exposure to opioids.